IDXX240621P680000
- 188.66
- 0.000.00%
IDEXX Laboratories Inc Newsroom
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/24/2024 2.88% Stifel $520 → $510 Maintains Hold 05/14/2024 20.23% Morgan Stanley $620 → $596 Maintains
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $510
Stifel analyst Jonathan Block maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and adjusts the target price from $520 to $510.According to TipRanks data, the analyst has a success rate
Express News | IDEXX Laboratories Inc : Stifel Cuts Target Price to $510 From $520
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520
IDEXX Laboratories (IDXX) has an average rating of outperform and price targets ranging from $400 to $641, according to analysts polled by Capital IQ. Price: 493.65, Change: -2.08, Percent Change: -0.
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Makes An Interesting Case
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,600 Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 11.41% on an annualized basis producing an average annual return of 22.31%. Currently, IDEXX Laboratories has a m
How Is The Market Feeling About IDEXX Laboratories?
IDEXX Laboratories's (NYSE:IDXX) short percent of float has risen 3.44% since its last report. The company recently reported that it has 1.75 million shares sold short, which is 2.71% of all regular s
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
IDEXX Laboratories (NASDAQ:IDXX) has had a rough three months with its share price down 9.0%. But if you pay close attention, you might gather that its strong financials could mean that the stock co
When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Idexx Laboratories Has Launched Catalyst Pancreatic Lipase Test For Canine And Feline Patients Suspected Of Pancreatitis, It Will Be Available In US And Canada This September, With Global Rollout To Over 70,000 Installed Base Planned In Q4 Of 2024
Idexx Laboratories Has Launched Catalyst Pancreatic Lipase Test For Canine And Feline Patients Suspected Of Pancreatitis, It Will Be Available In US And Canada This September, With Global Rollout To O
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst Pancreatic Lipase Test,...
Will Weakness in IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock Prove Temporary Given Strong Fundamentals?
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today
IDEXX Laboratories Inc(IDXX.US) Director Sells US$108.16K in Common Stock
$IDEXX Laboratories Inc(IDXX.US)$ Director Claflin Bruce L. sold 200 shares of common stock on May 17, 2024 at an average price of $540.8 for a total value of $108.16K.Source: Announcement What is sta
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,500 Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 11.59% on an annualized basis producing an average annual return of 24.04%. Currently, IDEXX Laboratories has a m
IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues
IDEXX Laboratories' IDXX business has been suffering due to complex macroeconomic conditions and unfavorable currency movement.
Form 144 | IDEXX Laboratories Inc(IDXX.US) Director Proposes to Sell 108.16K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $IDEXX Laboratories Inc(IDXX.US)$ Director Claflin Bruce L. intends to sell 200 shares of its common stock on May 17, with a total market value of approximately $108.16